Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Berndt

Showing results (101-110 of 155) with videos related to

Pageof 16
Sort By:
Nature Reviews. Drug Discovery|July 30, 2005
Industry funding of the FDA: effects of PDUFA on approval times and withdrawal ratesErnst R Berndt, Adrian H B Gottschalk, Tomas J Philipson, et al.
Medical Care|November 20, 2004
Effects of pharmaceutical promotion on adherence to the treatment guidelines for depressionJulie M Donohue, Ernst R Berndt, Meredith Rosenthal, et al.
International Journal of Clinical Practice|August 9, 2002
Healthcare expenditure in patients treated with venlafaxine or selective serotonin reuptake inhibitors for depression and anxietyG J Wan, W H Crown, E R Berndt, et al.
Managed Care Interface|June 29, 2002
Treatment costs of venlafaxine and selective serotonin-reuptake inhibitors for depression and anxietyGeorge J Wan, William H Crown, Ernst R Berndt, et al.
Physical Review Letters|January 15, 2011
Graphene on Ru(0001): contact formation and chemical reactivity on the atomic scaleS J Altenburg, J Kröger, B Wang, et al.
The American Journal of Pathology|May 1, 1987
Immunocytochemical analysis of Ewing's tumors. Patterns of expression of intermediate filaments and desmosomal proteins indicate cell type heterogeneity and pluripotential differentiationR Moll, I Lee, V E Gould, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Comparison of Stakeholder Metrics for Traditional and Adaptive Development and Licensing Approaches to Drug DevelopmentLynn G Baird, Mark R Trusheim, Hans-Georg Eichler, et al.
Pharmacoeconomics|June 20, 2008
Generic entry, reformulations and promotion of SSRIs in the USHaiden A Huskamp, Julie M Donohue, Catherine Koss, et al.
Physical Review Letters|February 5, 2013
Tunneling anisotropic magnetoresistance at the single-atom limitN Néel, S Schröder, N Ruppelt, et al.
Pharmacoeconomics|February 8, 2000
Cost effectiveness, quality-adjusted life-years and supportive care. Recombinant human erythropoietin as a treatment of cancer-associated anaemiaP Y Cremieux, S N Finkelstein, E R Berndt, et al.
Pageof 16

Showing results (101-110 of 155) with videos related to

Sort By:
Pageof 16
Nature Reviews. Drug Discovery|July 30, 2005
Industry funding of the FDA: effects of PDUFA on approval times and withdrawal ratesErnst R Berndt, Adrian H B Gottschalk, Tomas J Philipson, et al.
Medical Care|November 20, 2004
Effects of pharmaceutical promotion on adherence to the treatment guidelines for depressionJulie M Donohue, Ernst R Berndt, Meredith Rosenthal, et al.
International Journal of Clinical Practice|August 9, 2002
Healthcare expenditure in patients treated with venlafaxine or selective serotonin reuptake inhibitors for depression and anxietyG J Wan, W H Crown, E R Berndt, et al.
Managed Care Interface|June 29, 2002
Treatment costs of venlafaxine and selective serotonin-reuptake inhibitors for depression and anxietyGeorge J Wan, William H Crown, Ernst R Berndt, et al.
Physical Review Letters|January 15, 2011
Graphene on Ru(0001): contact formation and chemical reactivity on the atomic scaleS J Altenburg, J Kröger, B Wang, et al.
The American Journal of Pathology|May 1, 1987
Immunocytochemical analysis of Ewing's tumors. Patterns of expression of intermediate filaments and desmosomal proteins indicate cell type heterogeneity and pluripotential differentiationR Moll, I Lee, V E Gould, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Comparison of Stakeholder Metrics for Traditional and Adaptive Development and Licensing Approaches to Drug DevelopmentLynn G Baird, Mark R Trusheim, Hans-Georg Eichler, et al.
Pharmacoeconomics|June 20, 2008
Generic entry, reformulations and promotion of SSRIs in the USHaiden A Huskamp, Julie M Donohue, Catherine Koss, et al.
Physical Review Letters|February 5, 2013
Tunneling anisotropic magnetoresistance at the single-atom limitN Néel, S Schröder, N Ruppelt, et al.
Pharmacoeconomics|February 8, 2000
Cost effectiveness, quality-adjusted life-years and supportive care. Recombinant human erythropoietin as a treatment of cancer-associated anaemiaP Y Cremieux, S N Finkelstein, E R Berndt, et al.
Pageof 16